* Rxsight Inc RXST.OQ RXST.O is expected to show a rise
in
quarterly revenue when it reports results on May 6 for the
period ending March 31 2024
* The Aliso Viejo California-based company is expected to
report
a 57.6% increase in revenue to $27.559 million from $17.49
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Rxsight Inc is for a
loss
of 27 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Rxsight Inc
is
$63.00, above its last closing price of $61.68.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.36 -0.36 -0.26 Beat 28.2
Sep. 30 2023 -0.43 -0.43 -0.31 Beat 28.5
Jun. 30 2023 -0.47 -0.47 -0.39 Beat 17
Mar. 31 2023 -0.53 -0.53 -0.42 Beat 20.8
Dec. -0.77 -0.75 -0.56 Beat 25.1
31 2022
Sep. 30 2022 -0.71 -0.71 -0.61 Beat 14.5
Jun. 30 2022 -0.69 -0.69 -0.61 Beat 12.2
Mar. 31 2022 -0.65 -0.65 -0.64 Beat 1
This summary was machine generated May 4 at 02:05 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)